Access

Letter

Nature 451, 578-582 (31 January 2008) | doi:10.1038/nature06504; Received 10 August 2007; Accepted 30 November 2007

Open Innovation Challenges

Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart

Edward J. Miller1,6, Ji Li1,6,7, Lin Leng2, Courtney McDonald2, Toshiya Atsumi5, Richard Bucala2,3,6 & Lawrence H. Young1,4,6

  1. Cardiovascular Medicine Section of the Department of Internal Medicine,
  2. Rheumatology Section of the Department of Internal Medicine,
  3. Department of Pathology, and,
  4. Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA
  5. Department of Medicine II, Hokkaido University, Sapporo, 060-8638, Japan
  6. These authors contributed equally to this work.
  7. Present address: University of Wyoming School of Pharmacy, Laramie, Wyoming 82072, USA.

Correspondence to: Lawrence H. Young1,4,6 Correspondence and requests for materials should be addressed to L.H.Y. (Email: lawrence.young@yale.edu).

Top

Understanding cellular response to environmental stress has broad implications for human disease. AMP-activated protein kinase (AMPK) orchestrates the regulation of energy-generating and -consuming pathways, and protects the heart against ischaemic injury and apoptosis1. A role for circulating hormones such as adiponectin2 and leptin3 in the activation of AMPK has received recent attention. Whether local autocrine and paracrine factors within target organs such as the heart modulate AMPK is unknown. Here we show that macrophage migration inhibitory factor (MIF), an upstream regulator of inflammation4, is released in the ischaemic heart, where it stimulates AMPK activation through CD74, promotes glucose uptake and protects the heart during ischaemia-reperfusion injury. Germline deletion of the Mif gene impairs ischaemic AMPK signalling in the mouse heart. Human fibroblasts with a low-activity MIF promoter polymorphism5 have diminished MIF release and AMPK activation during hypoxia. Thus, MIF modulates the activation of the cardioprotective AMPK pathway during ischaemia, functionally linking inflammation and metabolism in the heart. We anticipate that genetic variation in MIF expression may impact on the response of the human heart to ischaemia by the AMPK pathway, and that diagnostic MIF genotyping might predict risk in patients with coronary artery disease.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Fat, keeping the heart healthy?

Nature Medicine News and Views (01 Oct 2005)